跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
LURASIDONA TEVA 18,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
LURASIDONA TEVA 18,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 22, 2024
Approval ID
6d066b607434d8f0
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
6d066b607434d8f0
Drug Cima Aemps Name
LURASIDONA TEVA 18,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89729
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2024-07-22
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
18,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
LURASIDONA HIDROCLORURO
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 22, 2024
Approval ID
6d066b607434d8f0
Type
Standard
Back to CIMA-AEMPS Approvals
LURASIDONA TEVA 18,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details